These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10810644)

  • 1. Approaches to gene-directed enzyme prodrug therapy (GDEPT).
    Springer CJ; Niculescu-Duvaz I
    Adv Exp Med Biol; 2000; 465():403-9. PubMed ID: 10810644
    [No Abstract]   [Full Text] [Related]  

  • 2. Strategies for enzyme/prodrug cancer therapy.
    Xu G; McLeod HL
    Clin Cancer Res; 2001 Nov; 7(11):3314-24. PubMed ID: 11705842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral vectors for gene-directed enzyme prodrug therapy.
    Schepelmann S; Springer CJ
    Curr Gene Ther; 2006 Dec; 6(6):647-70. PubMed ID: 17168697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prodrugs in genetic chemoradiotherapy.
    Patterson AV; Saunders MP; Greco O
    Curr Pharm Des; 2003; 9(26):2131-54. PubMed ID: 14529410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introduction to the background, principles, and state of the art in suicide gene therapy.
    Niculescu-Duvaz I; Springer CJ
    Mol Biotechnol; 2005 May; 30(1):71-88. PubMed ID: 15805578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene-directed enzyme prodrug therapy.
    Zhang J; Kale V; Chen M
    AAPS J; 2015 Jan; 17(1):102-10. PubMed ID: 25338741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prodrug cancer gene therapy.
    Altaner C
    Cancer Lett; 2008 Nov; 270(2):191-201. PubMed ID: 18502571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prodrugs for antibody- and gene-directed enzyme prodrug therapies (ADEPT and GDEPT).
    Niculescu-Duvaz I; Friedlos F; Niculescu-Duvaz D; Davies L; Springer CJ
    Anticancer Drug Des; 1999 Dec; 14(6):517-38. PubMed ID: 10834273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-directed enzyme-prodrug therapy.
    Pedley RB; Sharma SK; Hawkins RE; Chester KA
    Methods Mol Med; 2004; 90():491-514. PubMed ID: 14657581
    [No Abstract]   [Full Text] [Related]  

  • 10. Gene directed enzyme prodrug therapy for ovarian cancer: could GDEPT become a promising treatment against ovarian cancer?
    Nawa A; Tanino T; Luo C; Iwaki M; Kajiyama H; Shibata K; Yamamoto E; Ino K; Nishiyama Y; Kikkawa F
    Anticancer Agents Med Chem; 2008 Feb; 8(2):232-9. PubMed ID: 18288924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct retroviral delivery of human cytochrome P450 2B6 for gene-directed enzyme prodrug therapy of cancer.
    Kan O; Griffiths L; Baban D; Iqball S; Uden M; Spearman H; Slingsby J; Price T; Esapa M; Kingsman S; Kingsman A; Slade A; Naylor S
    Cancer Gene Ther; 2001 Jul; 8(7):473-82. PubMed ID: 11498768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent developments in gene-directed enzyme prodrug therapy (GDEPT) for cancer.
    Niculescu-Duvaz I; Cooper RG; Stribbling SM; Heyes JA; Metcalfe JA; Springer CJ
    Curr Opin Mol Ther; 1999 Aug; 1(4):480-6. PubMed ID: 11713763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendrimers as Non-Viral Vectors in Gene-Directed Enzyme Prodrug Therapy.
    Chis AA; Dobrea CM; Rus LL; Frum A; Morgovan C; Butuca A; Totan M; Juncan AM; Gligor FG; Arseniu AM
    Molecules; 2021 Oct; 26(19):. PubMed ID: 34641519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene directed enzyme/prodrug therapy of cancer: historical appraisal and future prospectives.
    Greco O; Dachs GU
    J Cell Physiol; 2001 Apr; 187(1):22-36. PubMed ID: 11241346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purine nucleoside phosphorylase and fludarabine phosphate gene-directed enzyme prodrug therapy suppresses primary tumour growth and pseudo-metastases in a mouse model of prostate cancer.
    Martiniello-Wilks R; Wang XY; Voeks DJ; Dane A; Shaw JM; Mortensen E; Both GW; Russell PJ
    J Gene Med; 2004 Dec; 6(12):1343-57. PubMed ID: 15493036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitroreductase gene-directed enzyme prodrug therapy: insights and advances toward clinical utility.
    Williams EM; Little RF; Mowday AM; Rich MH; Chan-Hyams JV; Copp JN; Smaill JB; Patterson AV; Ackerley DF
    Biochem J; 2015 Oct; 471(2):131-53. PubMed ID: 26431849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent progress in gene-directed enzyme prodrug therapy: an emerging cancer treatment.
    Both GW
    Curr Opin Mol Ther; 2009 Aug; 11(4):421-32. PubMed ID: 19649987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of oxazaphosphorines by cytochrome P450: application to gene-directed enzyme prodrug therapy for cancer.
    Roy P; Waxman DJ
    Toxicol In Vitro; 2006 Mar; 20(2):176-86. PubMed ID: 16293390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzyme/abzyme prodrug activation systems: potential use in clinical oncology.
    Nishi Y
    Curr Pharm Des; 2003; 9(26):2113-30. PubMed ID: 14529409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene-directed enzyme prodrug therapy for prostate cancer in a mouse model that imitates the development of human disease.
    Martiniello-Wilks R; Dane A; Voeks DJ; Jeyakumar G; Mortensen E; Shaw JM; Wang XY; Both GW; Russell PJ
    J Gene Med; 2004 Jan; 6(1):43-54. PubMed ID: 14716676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.